WallStreetZenWallStreetZen

NYSE: AGTI
Agiliti Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AGTI

Based on 3 analysts offering 12 month price targets for Agiliti Inc.
Min Forecast
$8.00-20.32%
Avg Forecast
$13.67+36.13%
Max Forecast
$23.00+129.08%

Should I buy or sell AGTI stock?

Based on 3 analysts offering ratings for Agiliti Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their AGTI stock forecasts and price targets.

AGTI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-07
lockedlocked$00.00+00.00%2024-01-04
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is AGTI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
19.16%

Forecast return on assets

Is AGTI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AGTI revenue forecast

What is AGTI's revenue in the next 2 years based on estimates from 4 analysts?
Avg 1 year Forecast
$1.2B+3.97%
Avg 2 year Forecast
$1.3B+8.97%
AGTI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AGTI revenue growth forecast

How is AGTI forecast to perform vs Health Information Services companies and vs the US market?
Company
4.39%
Industry
13.45%
Market
9.03%
AGTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AGTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AGTI vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
AGTI$10.04$13.67+36.13%Hold
OMCL$27.13$34.33+26.55%Strong Buy
PHR$20.46$30.36+48.41%Strong Buy
DH$6.73$10.38+54.16%Buy
SDGR$23.34$38.50+64.95%Buy
View Top Health Information Service Stocks

Agiliti Stock Forecast FAQ

Is Agiliti Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: AGTI) stock is to Hold AGTI stock.

Out of 3 analysts, 0 (0%) are recommending AGTI as a Strong Buy, 1 (33.33%) are recommending AGTI as a Buy, 1 (33.33%) are recommending AGTI as a Hold, 0 (0%) are recommending AGTI as a Sell, and 1 (33.33%) are recommending AGTI as a Strong Sell.

If you're new to stock investing, here's how to buy Agiliti stock.

What is AGTI's revenue growth forecast for 2024-2025?

(NYSE: AGTI) Agiliti's forecast annual revenue growth rate of 4.39% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.

Agiliti's revenue in 2024 is $1,174,604,000.On average, 4 Wall Street analysts forecast AGTI's revenue for 2024 to be $165,664,630,830, with the lowest AGTI revenue forecast at $164,281,656,151, and the highest AGTI revenue forecast at $166,608,092,222.

In 2025, AGTI is forecast to generate $173,635,556,981 in revenue, with the lowest revenue forecast at $172,698,878,202 and the highest revenue forecast at $174,258,879,065.

What is AGTI's forecast return on assets (ROA) for 2024-2026?

(NYSE: AGTI) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is AGTI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AGTI price target, the average AGTI price target is $13.67, with the highest AGTI stock price forecast at $23.00 and the lowest AGTI stock price forecast at $8.00.

On average, Wall Street analysts predict that Agiliti's share price could reach $13.67 by Mar 7, 2025. The average Agiliti stock price prediction forecasts a potential upside of 36.13% from the current AGTI share price of $10.04.

What is AGTI's forecast return on equity (ROE) for 2024-2026?

(NYSE: AGTI) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.